Montreal Chest Institute - McGill University Health Centre

Montreal, Quebec H2X 2P4

0 studies enrolling now · 4 studies all time

What they study most

HIV Infections, Pulmonary Disease, Chronic Obstructive

Studies at this site

• Dual Boosted - Protease Inhibitor (PI) Pharmacokinetics (PK) Trial (Tipranavir / Ritonavir) in Highly Treatment-experienced HIV-1 Infected Patients — Completed
• Efficacy and Safety Comparison of Tiotropium Inhalation Solution (Respimat Inhaler) and Spiriva HandiHaler in COPD — Completed
• Effect of Tiotropium (Spiriva) on Exercise Tolerance in COPD Patients — Completed
• 3 TPV/RTV Doses in Multiple ARV Experienced Patients - Tipranavir Dose Defining Study — Completed